Skip to content

Author

Amr A. El-Sehrawy

We have 12 of 60 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions.

Mutation-based liquid biopsy supports diagnosis and disease monitoring in hematologic malignancies, but interpretation of plasma variants may be complicated by clonal hematopoiesis, treatment-related changes, and nonmalignant blood-cell turnover. This structured narrative review evaluates whether cell-free DNA (cfDNA)...

Amr A. El-Sehrawy, Sarmad S. Abdullah, Guzalya Mamedova et al. · 0 citations
Review Open access Aug 2026

Mechanistic Insights Into the Association Between Gut Microbiota Diversity and Atherosclerosis, Acute Coronary Syndrome, and Peripheral Arterial Disease Progression

The gut microbiome has emerged as a potential contributor to cardiovascular diseases (CVDs), including atherosclerosis, acute coronary syndrome (ACS), and peripheral arterial disease (PAD). While observational studies link dysbiosis to CVD, causal relationships remain uncertain.

Amr A. El-Sehrawy, Usamah Sayed, Z. Nasirova et al. · 0 citations
Review Sep 2026

Sirtuin 1-microRNA regulatory networks in liver diseases: Mechanistic convergence, cellular senescence, and translational implications.

Metabolic dysfunction-associated steatotic liver disease, hepatotoxicity, liver fibrosis, and hepatocellular carcinoma are stages of chronic liver injury that occur in the setting of complex interactions of the various factors, including metabolic dysregulation, inflammation, oxidative stress, and cellular senescence....

Amr A. El-Sehrawy, Safa H. Radhie, Mirza R. Baig et al. · 0 citations
Open access Oct 2026

Neutrophil-to-lymphocyte ratio (NLR) in relation to metabolic profile and dietary antioxidant quality in adults with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a common metabolic condition characterized by hepatic steatosis and chronic low-grade inflammation, with oxidative stress playing a pivotal role in its progression. The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an accessible marker reflecting systemic inflamm...

Amr A. El-Sehrawy, Ahmed M. Salah, Ismail Kandil et al. · 0 citations
Review Aug 2026

Clinical significance of lncRNA-miRNA axes in ischemic stroke: Diagnostic value, prognostic relevance, and therapeutic potential.

Ischemic stroke and subsequent reperfusion injury are major causes of mortality and long-term neurological disability, driven by complex mechanisms of excitotoxicity, oxidative stress, neuroinflammation, endothelial dysfunction, and blood-brain barrier disruption. Increasing evidence indicates that long non-coding RNA...

Amr A. El-Sehrawy, I. Sapaev, O. Nematov et al. · 0 citations
Open access Sep 2026

Association of the cardiometabolic index with hepatic enzymes and metabolic profiles among adults with overweight and obesity

Growing evidence suggests that composite metabolic indices may offer valuable insights into obesity-related complications. The Cardiometabolic Index (CMI), a surrogate marker of adverse lipid profiles and central adiposity, has emerged as a promising indicator of cardiometabolic risk. Nevertheless, its association with...

Amr A. El-Sehrawy, Ismail Kandil, M. Maashi et al. · 0 citations
Open access Sep 2026

Dietary index for gut microbiota (DIGM) and cardiometabolic, inflammatory, and gut–brain-related biomarkers in adults with obesity: a cross-sectional study

Background The gut microbiota plays an important role in metabolic homeostasis and systemic inflammation, and dietary habits are major determinants of its composition and function. This study investigated the association between adherence to the Dietary Index for Gut Microbiota (DIGM) and cardiometabolic, inflammatory,...

Amr A. El-Sehrawy, Ismail Kandil, Safa Labib et al. · 0 citations
Review Aug 2026

AEG-1/MTDH: A central regulator of tumor progression, metabolic adaptation, and therapeutic resistance in gliomas.

Gen silencing studies demonstrate that AEG-1 knockdown reduces proliferation, promotes apoptosis, and enhances sensitivity to chemotherapeutic agents such as cisplatin, doxorubicin, and temozolomide, and support its potential as a target for combinatorial therapeutic strategies to improve outcomes in aggressive brain a...

S. Mohammad, A. Vasudevan, M. Al-Khreisat et al. · 0 citations
Review Open access Aug 2026

The CREM–IL-15 axis: decoding the persistence–exhaustion paradox in NK cell immunotherapy

In CAR-NK models, Rafei further demonstrated in CAR-NK models that CREM functions as a regulatory checkpoint limiting NK cell cytotoxicity and cytokine production, while its relevance in resting/native NK cells remains to be established.

Amr A. El-Sehrawy, M. Al-Khreisat, Jalpa R. Patel et al. · 0 citations
Meta-analysis Open access Aug 2026

Comprehensive in silico genomics analysis of global trends and host-specific emergence of aminoglycoside resistance in Staphylococcus aureus: a One-Health perspective

The global resistome is mapped to map the global resistome, quantify temporal and host-specific trends, and assess the association between genetic determinants and phenotypic resistance by analyzing over 110,000 S. aureus genomes.

Amr A. El-Sehrawy, S. Jasim, Haneen Fadhil Jasim et al. · 0 citations
Review Aug 2026

Circular Logic: Engineering Next-Generation Circular RNA Therapeutics for Precision Oncology.

This review argues that circular topology should be viewed as an active pharmacologic variable, not merely a stability enhancement, and dissect recent advances in cap-independent translation initiation, including IRES elements and m6A-driven mechanisms, rolling-circle translation for multi-epitope vaccine design, and p...

Amr A. El-Sehrawy, H. Al-Ameer, J. Rizaev et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.